2025 annual financial data
ADC Therapeutics 2025 Operating margin
ADC Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -133.21%.
Operating income was -108,379,000 USD and net income was -142,623,000 USD.
Operating cash flow was -141,174,000 USD.
Get free ADC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 81,357,000 USD
- Operating income
- -108,379,000 USD
- Net income
- -142,623,000 USD
- Operating cash flow
- -141,174,000 USD